Interleukin-10 as a CNS therapeutic: The obstacle of the blood-brain/blood-spinal cord barrier

Molecular Brain Research

Volumn 114, Issue 2, 2003, Pages 168-171

  Kastin, Abba J ^a   Akerstrom, Victoria ^a   Pan, Weihong ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Cytokine; Hydrogen bonding; Interleukin 10; Lipophilicity

Indexed keywords

INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN; CENTRAL NERVOUS SYSTEM; CIRCULATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; SPINAL CORD;

ANIMALIA;

EID: 0037785472     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00167-0     Document Type: Article

References (20)

1. Banks W.A., Farr S.A., La Scola M.E., Morley J.E. Intravenous human interleukin-1α impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J. Pharmacol. Exp. Ther. 299:2001;536-541.
2. Banks W.A., Fasold M.B., Kastin A.J. Measurement of efflux rates from brain to blood. Irvine G.B., Williams C.H. Methods in Molecular Biology, Neuropeptide Protocols. Vol. 73:1997;353-360 Humana Press, Totowa, NJ.
3. Bean A.G.D., Freiberg R.A., Andrade S., Menon S., Zlotnik A. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect. Immun. 61:1993;4937-4939.
4. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., Dietrich W.D. Systematically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma. 16:1999;851.
5. Chikhale E.G., Burton P.S., Borchardt R.T. The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism. J. Pharmacol. Exp. Ther. 273:1995;298-303.
6. Crisi G.M., Santambrogio L., Hochwald G.M., Smith S.R., Carlino J.A., Thorbecke G.J. Staphylococcal enterotoxin B and tumor-necrosis factor-α-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-β and interleukin-10. Eur. J. Immunol. 25:1995;3035-3040.
7. Cua D.J., Hutchins B., LaFace D.M., Stohlman S.A., Coffman R.L. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166:2001;602-608.
8. Di Santo E., Adami M., Bertorelli R., Ghezzi P. Systemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice. Eur. J. Pharmacol. 336:1997;197-202.
9. Gerard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., Velu T. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:1993;547-550.
10. Hosoya K., Tetsuka K., Nagase K., Tomi M., Saeki S., Ohtsuki S., Terasaki T. Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene. AAPS Pharmsci. 2:2000;E27.
11. Howard M., Muchamuel T., Andrade S., Menon S. Interleukin-10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1993;1205-1208.
12. Kastin A.J., Akerstrom V., Pan W. Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier: meaningful controls. Peptides. 22:2001;2127-2136.
13. Knoblach S.M., Faden A.I. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp. Neurol. 153:1998;143-151.
14. Koedel U., Bernatowicz A., Frei K., Fontana A., Pfister H.W. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J. Immunol. 157:1996;5185-5191.
15. Pan W., Kastin A.J. Upregulation of the transport system for TNFα at the blood-brain barrier. Arch. Physiol. Biochem. 109:2001;350-353.
16. Pan W., Kastin A.J. Penetration of neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier. Adv. Drug Deliv. Rev. 36:1999;291-298.
17. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple time uptake data. J. Cereb. Blood Flow Metab. 3:1983;1-7.
18. Plunkett J.A., Yu C.G., Easton J.M., Bethea J.R., Yezierski R.P. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp. Neurol. 168:2001;144-154.
19. Spera P.A., Ellison J.A., Feuerstein G.Z., Barone F.C. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 251:1998;189-192.
20. Terasaki T., Hosoya K. Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. Biol. Pharm. Bull. 24:2001;111-118.